Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018)

Twist Bioscience (TWST) has reported Preferred Stock Liabilities for 2 consecutive years, with $290.5 million the latest figure, recorded in Q3 2018.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $290.5 million in Q3 2018; TTM through Sep 2018 was $290.5 million, a N/A change from a year earlier, with the FY2018 full-year figure at $290.5 million, up 127.18% from the prior year.
• Preferred Stock Liabilities was $290.5 million for Q3 2018 at Twist Bioscience, up from $206.7 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $290.5 million in Q3 2018 and troughed at $130.9 million in Q4 2017.